OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Endocrinology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
OC45 - IL-1β/CXCL12 axis drives the crosstalk between PanNET cells and adipocytes	703
OC40 - Aldosterone/cortisol ratio as a new marker for diagnosing mild autonomous cortisol secretion (MACS). Investigating the effects of mild hypercortisolism on the renin-angiotensin-aldosterone syst	441
P12 - Morning spot urine iodine-to-creatinine ratio as a surrogate for 24-hour iodine excretion in adult non-pregnant women	199
Challenges estimating the effects of testosterone on health outcomes in transgender men: immortal time bias and other methodological concerns	167
EndoCompass project: research roadmap for growth disorders	103
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock	102
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis	102
EndoCompass project: the place of endocrinology in European research funding—an analysis of Horizon 2020	96
Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis	96
Neuroendocrine tumors and pregnancy: the French PregNET study	67
When selection becomes selection bias	66
Hemodynamic and microvascular abnormalities in P450 oxidoreductase deficiency: evidence for COX-dependent dysfunction	62
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial	59
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co	55
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy	55
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study	54
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study	53
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?	52
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study	52
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management	51
Two-year clinical outcomes of microwave ablation for benign thyroid nodules: results from a multicenter study	48
Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults	47
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment	43
Primary adrenal insufficiency in patients with CPOX gene mutations	42
Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study	41

Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis	41
OC05 - The clinical risk scores for Cushing’s Syndrome overlap with the phenotype of partial lipodystrophies	39
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors	37
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis	37
Response to the letter: health outcomes of testosterone therapy in transgender men: methodological issues warrant caution	36
Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study	36
Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity	35
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group	35
Updated Dutch 2026 Pediatric Differentiated Thyroid Carcinoma Guideline: Aligning with Europe	34
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?	34
Soluble alpha klotho—impact of biological variables and reference intervals for adults	34